EUVIMEDOpdag EUVIMED
MetaanalyseOpen access

Efficacy and Safety of Ion Channel Modulators in Painful Diabetic Neuropathy

Dandan Li iD, Linqi Ouyang, Zhen Chen, Yuanxiong Long, Guiming Deng iD

Diabetes, Obesity and Metabolism · 2026-09 · 28 (9) · 8675-8692

DOI: 10.1111/dom.71053 ↗

At a glance

Metaanalyse in Diabetes, Obesity and Metabolism, published online on 2026-07-08. Written by Dandan Li and 4 co-authors. Institution: Department of Discipline Construction and Scientific Research Management, The First Hospital of Hunan University of Chinese Medicine, Changsha, China. Major MEDLINE topics: Calcium Channel Blockers, Diabetic Neuropathies, Ion Channels, Sodium Channel Blockers. 71 references. The full text is freely available in PubMed Central. Funded by: Open Fund Project of the Provincial and Ministerial Co-construction State Key Laboratory Cultivation Base for Traditional Chinese Medicine Powder and Innovativ…, Natural Science Foundation of Hunan Province, Scientific Research Project of Hunan Health Commission.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aims

To systematically evaluate the efficacy and safety of ion channel modulators for the treatment of painful diabetic neuropathy (PDN). Materials and Methods We searched PubMed, Web of Science, Embase, and the Cochrane Library for randomized controlled trials (RCTs) in PDN patients treated with ion channel modulators. The primary outcome was the pain score. Secondary outcomes included the visual analog scale (VAS) score, 30% and 50% pain reduction, patient global impression of change (PGIC), sleep interference score, adverse events, and treatment discontinuation. Independent authors extracted the data and assessed the quality. Heterogeneity among studies was quantified using the I 2 statistic. The analyses were in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) reporting guidelines.

Results

A total of 36 RCTs comprising 6611 participants with PDN were included in the analyses, of which 21 were evaluated with calcium channel blockers, 12 with sodium channel blockers, 2 with TRPA1 antagonists, and 1 with P2X3 antagonists. Compared with placebo, ion channel modulators, particularly calcium channel blockers (mirogabalin, pregabalin, gabapentin, crisugabalin) and sodium channel antagonists (oxcarbazepine, lacosamide, lamotrigine, sodium valproate), can significantly reduce pain, VAS, and sleep interference scores, improve PGIC, and increase the proportion of patients achieving 30% and 50% pain reduction. The therapeutic effects of the TRPA1 antagonists and P2X3 antagonists did not differ significantly from those of the control. The adverse events of ion channel modulators were mild to moderate and well tolerated, but the risk of discontinuation due to adverse events was higher with mirogabalin and oxcarbazepine than with the other modulators.

Conclusion

Ion channel modulators, especially calcium channel blockers and sodium channel antagonists, have favourable safety profiles and beneficial effects on reducing pain and improving the quality of life of patients with PDN.

Subjects

MeSH terms (MEDLINE)

Calcium Channel BlockersDiabetic NeuropathiesIon ChannelsSodium Channel BlockersHumansPain MeasurementRandomized Controlled Trials as TopicTreatment Outcome

Author keywords

calcium channel blockersion channel modulatorspainpainful diabetic neuropathysodium channel antagonists

Substances

Calcium Channel BlockersIon ChannelsSodium Channel Blockers

Authors and institutions

  • Department of Discipline Construction and Scientific Research Management, The First Hospital of Hunan University of Chinese Medicine, Changsha, China.
  • Department of Pharmacy, The First Hospital of Hunan University of Chinese Medicine, Changsha, China.
  • National Key Laboratory Cultivation Base of Chinese Medicinal Powder & Innovative Medicinal Jointly Established by Province and Ministry, Changsha, China.

ORCID profiles: Dandan Li, Guiming Deng

Funding

  • Open Fund Project of the Provincial and Ministerial Co-construction State Key Laboratory Cultivation Base for Traditional Chinese Medicine Powder and Innovativ…
  • Natural Science Foundation of Hunan Province
  • Scientific Research Project of Hunan Health Commission
  • Scientific Research Fund Project of Hunan University of Chinese Medicine

Cite

APA

Li, D., Ouyang, L., Chen, Z., Long, Y., & Deng, G. (2026). Efficacy and Safety of Ion Channel Modulators in Painful Diabetic Neuropathy. Diabetes, Obesity and Metabolism, 28(9), 8675-8692. https://doi.org/10.1111/dom.71053

Vancouver

Li D, Ouyang L, Chen Z, Long Y, Deng G. Efficacy and Safety of Ion Channel Modulators in Painful Diabetic Neuropathy. Diabetes, Obesity and Metabolism. 2026;28(9):8675-8692. doi:10.1111/dom.71053

BibTeX
@article{Li2026,
  author = {Li, Dandan and Ouyang, Linqi and Chen, Zhen and Long, Yuanxiong and Deng, Guiming},
  title = {Efficacy and Safety of Ion Channel Modulators in Painful Diabetic Neuropathy},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {9},
  pages = {8675--8692},
  doi = {10.1111/dom.71053}
}
Start for free →